Reticulocyte blood test for bone marrow activity in B-cell cancers
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This trial looks at a simple blood test that may show how well your bone marrow is making new red blood cells. It could help doctors understand and monitor your condition without extra procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 years or older).
- You have been recently diagnosed with a chronic B-cell blood cancer (such as chronic lymphocytic leukemia or similar).
- You have not received chemotherapy yet.
- You have not had a blood transfusion in the last 2 weeks.
- You are not currently taking iron, vitamin B12, or other blood-building supplements.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at certain markers on your blood cancer cells to understand them better. By joining, you help doctors learn more about your disease, which may guide future care.
This study looks at certain proteins on B-cell blood cancer cells to understand them better. It may help doctors learn more about these cancers, but it is not a treatment trial.
This study checks if two natural substances in your blood (called cytokines) are linked to how active your leukemia is. It aims to help doctors better understand and possibly predict the disease, which could guide future treatment.
This study looks at routine blood test results (called CBC) in people who have just been diagnosed with acute lymphoblastic leukemia (ALL), a type of blood cancer. The goal is to see if certain blood levels can help doctors understand the disease better and guide treatment.
This study looks at blood test results (called cell population data) to see if they can help doctors better understand or diagnose chronic lymphoproliferative disorders (types of blood cancer) and viral hepatitis (liver infection). The goal is to find simple, early clues that might make diagnosis faster or easier.
This study measures how your body’s metabolism works in people with chronic lymphocytic leukemia (CLL). It uses blood tests, and for some people, a bone marrow sample, to better understand what’s happening and potentially guide future treatments.
Hear when a new B Chronic Lymphocytic Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.